Lantern Pharma Inc.LTRNNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank33
3Y CAGR-47.4%
5Y CAGR+43.6%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-47.4%/yr
Annual compound
5Y CAGR
+43.6%/yr
Recent deceleration
Percentile
P33
Within normal range
vs 5Y Ago
6.1x
Strong expansion
Streak
3 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $7.51M | -65.8% |
| 2023 | $21.94M | -41.0% |
| 2022 | $37.20M | -27.8% |
| 2021 | $51.52M | +167.9% |
| 2020 | $19.23M | +1460.8% |
| 2019 | $1.23M | +176.8% |
| 2018 | $445163.00 | - |